The use of Cord Tissue Stem Cells for treatments are still in the clinical trial phase, but they have great potential for future use in the treatment of conditions such as heart disease, diabetes, strokes, spinal cord injuries, and more..

Research indicates that these cord stem cells, mainly Mesenchymal stem cells (MSCs) found in the Wharton’s Jelly of the umbilical cord have the unique ability to rapidly regenerate and differentiate themselves into various tissues and organ cells, including heart, nerve, cartilage, bone, muscle, liver, cartilage and fat tissue.

Currently, there are more than 1,000 ongoing clinical trials1 involving MSCs, and more than 6,000 articles are published, which further emphasise the potential for MSCs in future Stem Cell therapies.

StemCord takes an extra step in culturing stem cells prior to storage to ensure the harvest of quality stem cells, as research has shown that cells extracted from thawed frozen cord tissues exhibited poorer cell recoveries, decreased efficiency, and slower growth characteristics³.

Here’s why it matters..

While many Cord Blood Banks choose to store the umbilical cord as a whole or in segments, research has shown that culturing the stem cells before storage increases cell yield 8x more⁴ than the cells yielded from segmented frozen tissues.

Higher Cell Count
Research has shown that culturing first from a fresh cord before storage, gives 8x more cells yield.

Readily Available for Treatment
With StemCord’s CultureFIRST process, you can be assured your Cord Stem Cells are readily available as soon as they are needed. This differs from other banks that choose to store whole or chopped Cord Tissues without extracting the Stem Cells prior to storage.

Further Possibilities For Your Futures
These Cord Stem Cells can be further multiplied with a culturing process if the therapy (for certain conditions) requires larger doses of cord stem cells.